Science of assessment

Annals of the Rheumatic Diseases

Volumn 64, Issue SUPPL. 2, 2005, Pages

  Bellamy, N ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; CONSENSUS; CULTURAL FACTOR; DISABILITY; HEALTH STATUS; INFORMATION PROCESSING; MEASUREMENT; MUSCULOSKELETAL SYSTEM; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RELIABILITY; SKIN MANIFESTATION; STANDARDIZATION; VALIDATION PROCESS;

ARTHRITIS, PSORIATIC; HEALTH STATUS INDICATORS; HUMANS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 14244260625     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.031567     Document Type: Conference Paper

References (32)

1. Bruce IN. Psoriatic arthritis: clinical features. In: Hochberg MC, Silman AJ, Smolen JS, Weinblalt ME, Weisman MH, eds. Practical Rheumatology, 3rd edn, vol 2. Edinburgh: Mosby, 2003:1241-52.
2. Bellamy N. Musculoskeletal Clinical Metrology. Lancaster: Kluwer Academic Publishers, 1993:135-40.
3. Bellamy N, Buchanan WW. Clinical outcome measurement. In: Dieppe P, Schumacher HR Jr, Wollheim FA, eds. Classic Papers in Rheumatology, 1st edn. London: Martin Dunitz Ltd, 2002:2-3.
4. Bellamy N. Principles of outcome assessment. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Practical Rheumatology, 3rd edn, vol 1. Edinburgh: Mosby, 2003:21-30.
5. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
6. World Health Organization. ICIDH-2, An international classification of impairments, activities and participation. Geneva: WHO, 1997.
7. World Health Organization. ICF. International Classification of Functioning, Disability and Health. Geneva: WHO, 2001.
8. Carmines EG, Zeller RA. Reliability and validity assessment. Beverly Hills: Sage Publications, 1979:5-71.
9. Bellamy N, Campbell J, Syrotuik J. Comparative study of self-rating pain scales in rheumatoid arthritis patients. Curr Med Res Opin 1999; 15: 121-7.
10. Bellamy N, Campbell J, Syrotuik J. Comparative study of self-rating pain scales in osteoarthritis patients. Curr Med Res Opin 1999;15:113-19.
11. Bellamy N, Muirden KD, Brooks PM, Barraclough D, Tellus MM, Campbell J. A survey of outcome measurement procedures in routine rheumatology outpatient practice in Australia. J Rheumatol 1999;26:1593-9.
12. Bellamy N, Kaloni S, Pope J, Coulter K, Campbell J. Quantitative rheumatology: a survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. J Rheumatol 1998;25:852-8.
13. Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N, Bloch DA, et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage 1996;4:217-43.
14. Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 1997;24:799-802.
15. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;3A:729-40.
16. van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol 1997;24:2225-9.
17. Felson DT, Andersen JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
18. Felson DT, Anderson JJ, Lange ML, Wells G, LaValley MP. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum 1998;41:1504-70.
19. Dougados M, Leclaire P, van der Heijde D, Bloch DA, Bellamy N, Altman RD. Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthritis Cartilage 2000;8:395-403.
20. Pham T, Van Der Heijde D, Lassere M, Altman RD, Anderson JJ, Bellamy N, et al. OMERACT-OARSI. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria, J Rheumatol 2003;30:1648-54.
21. van Tubergen A, van der Heijde D, Anderson J, Landewe R, Dougados M, Braun J, et al. Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel. Ann Rheum Dis 2003;62:215-21.
22. Beaton DE, Bombardier C, Katz JN, Wright JG, Wells G, Boers M, et al. OMERACT MCID Working Group. Looking for important change/differences in studies of responsiveness. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol 2001;28:400-5.
23. Ujfalussy I, Koo E. Measurement of disease activity in psoriatic arthritis. Extended report. Z Rheumatol 2003;62:60-5.
24. Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996;39:2013-20.
25. Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropatnies: a Department of Veterans Affairs cooperative study. Arthritis Rheum 1999;42:2325-9.
26. Gladman DD, Farewell V, Buskila D, Goodman R, Hamilton L, Langevitz P. Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 1990;17:02-4.
27. Duffy CM, Watanabe Duffy KN, Gladman DD, Brubacher BB, Buskila D. The utility of the arthritis impact measurement scales for patients with psoriatic arthritis. J Rheumatol 1992;19:1727-32.
28. Blackmore MG, Gladman DD, Husted J, Long JA, Farewell VT. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol 1995;22:886-93.
29. Husted J, Gladman DD, Farewell VT, Long JA. Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic arthritis. J Rheumatol 1996;23:1015-19.
30. Husted J, Gladman DD, Long JA, Farewell VT. Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis. J Rheumatol 1996;23:1932-7.
31. Taccari E, Spadaro A, Rinaldi T, Riccieri V, Sensi F. Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis. Rev Rhum Engl Ed 1998;65:751-8.
32. Husted JA, Gladman DD, Cook RJ, Farewell VT. Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis. J Rheumatol 1998;25:2146-55.